Review article: The role of statins in reducing perioperative cardiac risk: Physiologic and clinical perspectives (Q36641901)

15 August 2017

1 reference

title

Review article: The role of statins in reducing perioperative cardiac risk: Physiologic and clinical perspectives (English)

1 reference

15 August 2017

1 reference

Nader N Boushra

1

1 reference

15 August 2017

Muhammad Muntazar

series ordinal

2

1 reference

15 August 2017

publication date

1 November 2006

1 reference

Canadian Journal of Anaesthesia

15 August 2017

published in

1 reference

15 August 2017

volume

53

1 reference

15 August 2017

issue

11

1 reference

15 August 2017

page(s)

1126-1147

1 reference

Cardiac complications after elective major vascular surgery

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Perioperative myocardial injury: individual and population implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Biologic aspects of vulnerable plaque

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Towards understanding acute destabilization of vulnerable atherosclerotic plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Vulnerable plaque: pathobiology and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Correlation of location of acute myocardial infarct after noncardiac vascular surgery with preoperative dobutamine echocardiographic findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Pathology of fatal perioperative myocardial infarction: implications regarding pathophysiology and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Structure-dependent dynamic mechanical behavior of fibrous caps from human atherosclerotic plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Left ventricular muscle mass and elevated heart rate are associated with coronary plaque disruption.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Morphology of vulnerable coronary plaque: insights from follow-up of patients examined by intravascular ultrasound before an acute coronary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Withdrawal of statins increases event rates in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Statins inhibit oxidized-LDL-mediated LOX-1 expression, uptake of oxidized-LDL and reduction in PKB phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

The effect of statins on mRNA levels of genes related to inflammation, coagulation, and vascular constriction in HUVEC. Human umbilical vein endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Modulation of inflammatory mediators and PPARgamma and NFkappaB expression by pravastatin in response to lipoproteins in human monocytes in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Association between reduced low density lipoprotein oxidation and inhibition of monocyte chemoattractant protein-1 production in statin-treated subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Increased transforming growth factor-beta(1) circulating levels and production in human monocytes after 3-hydroxy-3-methyl-glutaryl-coenzyme a reductase inhibition with pravastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Simvastatin inhibits PDGF-induced DNA synthesis in human glomerular mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Modulation of COX-2 expression by statins in human aortic smooth muscle cells. Involvement of geranylgeranylated proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Statins alter smooth muscle cell accumulation and collagen content in established atheroma of watanabe heritable hyperlipidemic rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Induction of apoptosis and inhibition of migration of inflammatory and vascular wall cells by cerivastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Statin-induced inhibition of the Rho-signaling pathway activates PPARalpha and induces HDL apoA-I

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Statins have biphasic effects on angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Diabetes and progression of coronary calcium under the influence of statin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia: effects of statin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Statin prevents tissue factor expression in human endothelial cells: role of Rho/Rho-kinase and Akt pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors increase fibrinolytic activity in rat aortic endothelial cells. Role of geranylgeranylation and Rho proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Atorvastatin reduces platelet-oxidized-LDL receptor expression in hypercholesterolaemic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Rapid improvement of nitric oxide bioavailability after lipid-lowering therapy with cerivastatin within two weeks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Effect of pravastatin on endothelial function in patients with coronary artery disease (cholesterol-independent effect of pravastatin).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Cholesterol lowering with pravastatin improves resistance artery endothelial function: report of six subjects with normal coronary arteriograms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Influence of HMG-CoA reductase inhibitors on markers of coagulation, systemic inflammation and soluble cell adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Effects of lipid-lowering by simvastatin on human atherosclerotic lesions: a longitudinal study by high-resolution, noninvasive magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Regression of coronary atherosclerosis by simvastatin: a serial intravascular ultrasound study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Comparison of levels of matrix metalloproteinases, tissue inhibitor of metalloproteinases, interleukins, and tissue necrosis factor in carotid endarterectomy specimens from patients on versus not on statins preoperatively

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Statins and blood coagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Simvastatin depresses blood clotting by inhibiting activation of prothrombin, factor V, and factor XIII and by enhancing factor Va inactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Effects of statin on plaque stability and thrombogenicity in hypercholesterolemic patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

The pathophysiology of perioperative myocardial infarction: facts and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Triggers of perioperative myocardial ischaemia and infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Perioperative catecholamine changes in cardiac risk patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Assessment of the patient with cardiac disease: an anesthesiologist's paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Perioperative activation of hemostasis in vascular surgery patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Multicentric inflammation in epicardial coronary arteries of patients dying of acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Extensive development of vulnerable plaques as a pan-coronary process in patients with myocardial infarction: an angioscopic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Elevated C-reactive protein values and atherosclerosis in sudden coronary death: association with different pathologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Preoperative C-reactive protein and outcome after coronary artery bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Perioperative beta-adrenergic receptor blockade: physiologic foundations and clinical controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Prophylactic atenolol reduces postoperative myocardial ischemia. McSPI Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Predictors of cardiac events after major vascular surgery: Role of clinical characteristics, dobutamine echocardiography, and beta-blocker therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Low-dose metoprolol CR/XL and fluvastatin slow progression of carotid intima-media thickness: Main results from the Beta-Blocker Cholesterol-Lowering Asymptomatic Plaque Study (BCAPS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Effect of controlled release/extended release metoprolol on carotid intima-media thickness in patients with hypercholesterolemia: a 3-year randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

A combination of statins and beta-blockers is independently associated with a reduction in the incidence of perioperative mortality and nonfatal myocardial infarction in patients undergoing abdominal aortic aneurysm surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Statins are associated with a reduced infrarenal abdominal aortic aneurysm growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Patients undergoing infrainguinal bypass to treat atherosclerotic vascular disease are underprescribed cardioprotective medications: effect on graft patency, limb salvage, and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Statin therapy is associated with improved patency of autogenous infrainguinal bypass grafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Determinants of carotid endarterectomy anatomic durability: effects of serum lipids and lipid-lowering drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Statins are associated with better outcomes after carotid endarterectomy in symptomatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Preoperative statin therapy and troponin T predict early complications of coronary artery surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Preoperative statin use and outcomes following cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Preoperative thallium scanning, selective coronary revascularization, and long-term survival after major vascular surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Interaction between simvastatin and metoprolol with respect to cardiac beta-adrenoceptor density, catecholamine levels and perioperative catecholamine requirements in cardiac surgery patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

beta-adrenergic receptor blockade in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Statins in the prevention of perioperative cardiovascular complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Fluvastatin and bisoprolol for the reduction of perioperative cardiac mortality and morbidity in high-risk patients undergoing non-cardiac surgery: rationale and design of the DECREASE-IV study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Determination of lipid profiles and use of statins in patients with ischemic stroke or transient ischemic attack

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Statin therapy improves cardiovascular outcome of patients with peripheral artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Effects of rosuvastatin, atorvastatin, simvastatin, and pravastatin on atherogenic dyslipidemia in patients with characteristics of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Healed plaque ruptures and sudden coronary death: evidence that subclinical rupture has a role in plaque progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Statin therapy: a potentially useful peri-operative intervention in patients with cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Preoperative risk stratification using electron beam computed tomography in elective vascular surgery: relationship to clinical risk prediction and postoperative complications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Benefit-risk assessment of Rosuvastatin 10 to 40 milligrams

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

The effects of concurrent atorvastatin therapy on the pharmacokinetics of intravenous midazolam

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Rhabdomyolysis in association with simvastatin and amiodarone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Lipid-independent effects of statins on endothelial function and bioavailability of nitric oxide in hypercholesterolemic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Rapid Effect of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibition on Coronary Endothelial Function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Simvastatin blunts endotoxin-induced tissue factor in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

The pharmaco-economics of peri-operative statin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Severe rhabdomyolysis after laparoscopic surgery for adenocarcinoma of the rectum in two patients treated with statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Massive postoperative rhabdomyolysis following combined CABG/abdominal aortic replacement: a possible association with HMG-CoA reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

There is no evidence for an increase in acute coronary syndromes after short-term abrupt discontinuation of statins in stable cardiac patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Rhabdomyolysis and myalgia associated with anticholesterolemic treatment as potential signs of malignant hyperthermia susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Multiple Complex Coronary Plaques in Patients with Acute Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Early and Sustained Survival Benefit Associated With Statin Therapy at the Time of Percutaneous Coronary Intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Widespread Myocardial Inflammation and Infarct-Related Artery Patency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03022882

Multiple atherosclerotic plaque rupture in acute coronary syndrome: a three-vessel intravascular ultrasound study

21 January 2018

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.1161/01.CIR.0000025609.13806.31

Identifiers

DOI

10.1007/BF03022882

1 reference

15 August 2017

1 reference